EVALUATION OF FIBROBLAST ACTIVATION PROTEIN-ALPHA (FAP) AS A DIAGNOSTIC MARKER AND THERAPEUTIC TARGET IN PROSTATE CANCER

The Johns Hopkins University

Investigators